# Allogene Therapeutics, Inc.: Form 8-K, filed Feb 25, 2025

- Company: [Allogene Therapeutics, Inc.](/companies/allo.md) (CIK 1737287)
- Form: 8-K
- Filed: 2025-02-25
- Accepted by EDGAR: Feb 25, 2025, 16:18 ET
- Period: 2025-02-19
- Accession: 0001193125-25-035162
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737287/000119312525035162/d926019d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737287/000119312525035162/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737287/000119312525035162/d926019d8k.htm

Filed Feb 25, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-035162. Last ingested by Listed: Nov 5, 2026, 17:19 ET. No prices; not investment advice.